Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25. [electronic resource]
- Blood Aug 2006
- 1007-12 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
0006-4971
10.1182/blood-2005-11-4757 doi
Animals Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols--therapeutic use Astatine--therapeutic use Daclizumab Disease Models, Animal Drug Evaluation, Preclinical--methods Epitopes Immunoglobulin G--therapeutic use Leukemia-Lymphoma, Adult T-Cell--drug therapy Mice Mice, Inbred NOD Mice, SCID Receptors, Interleukin-2--immunology Survival Rate